Tuesday, July 14, 2026
NewsWhite
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
HEALTH
Unverified

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

July 11, 2026·Source: CNBC·8 views

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

Originally reported by CNBC. Read the original article

Related Articles